2022
DOI: 10.1016/s0016-5085(22)62354-0
|View full text |Cite
|
Sign up to set email alerts
|

Tu1516: IDENTIFICATION AND DEVELOPMENT OF A 1ST IN CLASS NATURALLYDERIVED PROTEIN THAT DRIVES MUCOSAL HEALING AND IS ORALLY DELIVERED BY AN ENGINEERED CELLULAR THERAPY TARGETING THE GASTRO-INTESTINAL TRACT

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles